Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ImPrecise Oversight? Cordis Monitoring Gaps Yield Second Warning Letter

This article was originally published in The Gray Sheet

Executive Summary

J&J Cordis says it is developing more "robust" systems and processes for overseeing clinical studies in response to FDA's warning letter faulting the company for sponsor monitoring lapses in its SAPPHIRE trial

You may also be interested in...



Cordis Precise, Guidant Acculink Are First “Approvable” Carotid Stents

Johnson & Johnson/Cordis and Guidant are working to satisfy FDA's remaining conditions for approval of their respective Precise and Acculink carotid stent systems, as outlined in recent "approvable" letters

Cordis Precise, Guidant Acculink Are First “Approvable” Carotid Stents

Johnson & Johnson/Cordis and Guidant are working to satisfy FDA's remaining conditions for approval of their respective Precise and Acculink carotid stent systems, as outlined in recent "approvable" letters

J&J Precise Panel Vote Nearly Split On Carotid Disease Subgroup Benefit

Carotid revascularization with Cordis' Precise stent is a safe alternative to surgery for high-risk patients, although its benefit to asymptomatic patients remains unclear, an FDA panel concluded April 21

Related Content

UsernamePublicRestriction

Register

MT020619

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel